Tumor Lysis Syndrome: Causes, Symptoms, and Treatment

What is Tumor Lysis Syndrome?

Tumor lysis syndrome (TLS) is a serious, potentially life-threatening condition that occurs when cancer cells break down (lyse) rapidly, releasing their contents into the bloodstream. This sudden release can overwhelm the body's normal waste removal processes, leading to dangerous imbalances in electrolytes and kidney damage.

TLS most commonly occurs after starting cancer treatment, especially chemotherapy, but it can also happen spontaneously in fast-growing cancers. The syndrome is characterized by high levels of uric acid, potassium, and phosphate in the blood, along with low levels of calcium. These imbalances can cause severe complications, including kidney failure, heart arrhythmias, seizures, and even death if not treated promptly.

Source: National Cancer Institute (NCI), Mayo Clinic

Common Causes

Tumor lysis syndrome is most often triggered by the treatment of cancers that grow quickly or are large in size. However, it can also occur spontaneously in some cases. Below are the most common causes:

• Chemotherapy: Especially for cancers like leukemia and lymphoma, which are highly sensitive to treatment.
• Targeted therapy or immunotherapy: Newer cancer treatments can also trigger rapid cell death.
• Radiation therapy: Particularly when treating large tumors.
• Steroids: Often used in cancer treatment, they can accelerate tumor breakdown.
• Spontaneous TLS: Can occur in very aggressive cancers before treatment begins, such as:
  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia (AML)
  • Burkitt lymphoma
  • Other high-grade non-Hodgkin lymphomas
• Large tumor burden: Cancers with a high number of cells or large tumor size are at higher risk.
• High white blood cell count: Often seen in leukemias, increasing the risk of TLS.
• Kidney dysfunction: Pre-existing kidney problems can worsen the effects of TLS.
• Dehydration: Reduces the body's ability to flush out excess waste products.
• Certain cancers: Including chronic lymphocytic leukemia (CLL), multiple myeloma, and some solid tumors like small cell lung cancer.

Source: American Society of Clinical Oncology (ASCO), UpToDate

Associated Symptoms

The symptoms of tumor lysis syndrome are primarily due to the metabolic imbalances caused by the rapid release of cellular contents. These symptoms can develop within hours to days after starting treatment. Common signs include:

• Nausea and vomiting: Often one of the first signs, due to high electrolyte levels affecting the digestive system.
• Fatigue and weakness: Caused by electrolyte imbalances, particularly high potassium or low calcium.
• Muscle cramps or spasms: Low calcium levels can cause muscle irritability.
• Irregular heartbeat (arrhythmia): High potassium (hyperkalemia) can disrupt heart rhythm, leading to palpitations or even cardiac arrest.
• Decreased urine output: A sign of kidney dysfunction due to uric acid or calcium phosphate crystals blocking the kidneys.
• Swelling (edema): Fluid retention due to kidney problems.
• Confusion or seizures: Low calcium or high phosphate levels can affect the nervous system.
• Shortness of breath: Can occur due to fluid buildup or heart complications.

In severe cases, TLS can lead to kidney failure, cardiac arrest, or sudden death if not treated immediately.

Source: National Center for Biotechnology Information (NCBI)

When to See a Doctor

Tumor lysis syndrome is a medical emergency. If you or a loved one is undergoing cancer treatment (or has a known cancer diagnosis) and experiences any of the following, seek medical attention immediately:

• Severe nausea or vomiting that prevents eating or drinking.
• Muscle weakness, cramps, or spasms that are new or worsening.
• Irregular heartbeat, chest pain, or dizziness.
• Signs of kidney problems, such as:
  • Very little or no urine output.
  • Swelling in the legs, ankles, or feet.
  • Confusion or extreme fatigue.
• Seizures or sudden changes in mental status.
• Shortness of breath or difficulty breathing.

If you are starting cancer treatment, your healthcare team will likely monitor you closely for signs of TLS, especially in the first few days. Do not wait for symptoms to worsen—early intervention is critical.

Source: Centers for Disease Control and Prevention (CDC)

Diagnosis

Tumor lysis syndrome is diagnosed through a combination of blood tests, urine tests, and clinical evaluation. If you are at high risk (e.g., starting chemotherapy for a fast-growing cancer), your doctor may perform baseline tests and monitor you closely. Diagnostic steps include:

Blood Tests

These are the primary tools for diagnosing TLS. Key tests include:

• Electrolyte panel: Measures levels of:
  • Potassium (high in TLS).
  • Phosphate (high in TLS).
  • Calcium (low in TLS).
  • Sodium and bicarbonate (may also be abnormal).
• Uric acid level: Elevated in TLS due to the breakdown of cancer cells.
• Kidney function tests:
  • Blood urea nitrogen (BUN).
  • Creatinine (high levels indicate kidney damage).
• Complete blood count (CBC): To assess white blood cell count and other blood components.
• Lactate dehydrogenase (LDH): Often elevated in TLS due to cell breakdown.

Urine Tests

• Urine output measurement (low output is a red flag).
• Uric acid levels in urine.
• Check for crystals (e.g., uric acid or calcium phosphate) that can clog the kidneys.

Imaging and Other Tests

• Electrocardiogram (ECG): To check for heart rhythm abnormalities due to high potassium.
• Kidney ultrasound or CT scan: If kidney obstruction or damage is suspected.

Risk Stratification

Doctors classify patients into low, intermediate, or high risk for TLS based on:

• Type of cancer (e.g., Burkitt lymphoma is high risk).
• Tumor size and growth rate.
• Kidney function before treatment.
• White blood cell count (high counts increase risk).
• LDH levels (high LDH suggests rapid cell turnover).

Source: Cleveland Clinic, World Health Organization (WHO)

Treatment Options

Treatment for tumor lysis syndrome focuses on preventing complications, correcting electrolyte imbalances, and supporting kidney function. Early intervention is key. Treatment may include:

Medical Treatments

• Intravenous (IV) fluids: Hydration helps flush out excess uric acid and electrolytes. Patients often receive large volumes of fluids to protect the kidneys.
• Medications to lower uric acid:
  • Allopurinol: Blocks uric acid production.
  • Rasburicase: An enzyme that breaks down uric acid (used in severe cases).
• Electrolyte management:
  • Potassium binders (e.g., sodium polystyrene sulfonate) for high potassium.
  • Phosphate binders (e.g., aluminum hydroxide) to lower phosphate.
  • Calcium gluconate (IV) for low calcium, but used cautiously to avoid worsening phosphate levels.
• Diuretics: May be used to increase urine output if fluid overload is a concern.
• Dialysis: In severe cases, dialysis may be needed to remove excess electrolytes and support kidney function.

Monitoring and Supportive Care

• Frequent blood tests (every 6–12 hours initially) to monitor electrolyte and kidney function.
• Continuous heart monitoring (telemetry) for arrhythmias due to high potassium.
• Nutritional support if nausea or vomiting prevents eating.

Adjusting Cancer Treatment

In some cases, chemotherapy may be delayed or dose-adjusted to reduce the risk of TLS, especially in high-risk patients. Alternatively, preventive measures (see below) are taken before starting treatment.

Home Care (After Stabilization)

Once stabilized, patients may need to:

• Continue taking prescribed medications (e.g., allopurinol, phosphate binders).
• Stay well-hydrated (unless fluid-restricted due to kidney issues).
• Follow a low-potassium, low-phosphate diet if advised by a doctor or dietitian.
• Monitor for recurring symptoms and report them immediately.

Source: National Institutes of Health (NIH), American Cancer Society

Prevention Tips

Preventing tumor lysis syndrome is critical, especially for high-risk patients. If you or a loved one is about to start cancer treatment, ask your healthcare team about preventive strategies. Common approaches include:

Before Starting Treatment

• Risk assessment: Your doctor will evaluate your risk based on cancer type, tumor size, kidney function, and other factors.
• Hydration: IV fluids may be started 24–48 hours before chemotherapy to help the kidneys flush out waste.
• Medications:
  • Allopurinol: Often started 1–2 days before treatment to lower uric acid.
  • Rasburicase: Used in very high-risk patients (e.g., Burkitt lymphoma) to rapidly reduce uric acid.
• Electrolyte monitoring: Baseline blood tests to check kidney function and electrolyte levels.

During Treatment

• Continue IV hydration as directed.
• Frequent blood tests (sometimes every 6 hours) to catch TLS early.
• Avoid medications that can worsen kidney function (e.g., NSAIDs like ibuprofen).
• Follow dietary recommendations, such as limiting foods high in potassium or phosphate if advised.

Lifestyle and Dietary Tips

While diet alone cannot prevent TLS, certain adjustments may help support kidney function and reduce strain:

• Stay hydrated: Drink plenty of water unless your doctor advises fluid restriction.
• Limit high-potassium foods if at risk for hyperkalemia, such as:
  • Bananas, oranges, potatoes, tomatoes, and spinach.
  • Salt substitutes (often high in potassium).
• Limit high-phosphate foods, such as:
  • Dairy products, nuts, seeds, and processed foods.
• Avoid alcohol, which can dehydrate you and stress the kidneys.

Source: National Kidney Foundation

Emergency Warning Signs

Tumor lysis syndrome can become life-threatening very quickly. Seek emergency medical care or call 911 if you experience any of the following:

• Chest pain or pressure: Could indicate a heart rhythm problem due to high potassium.
• Severe shortness of breath: May signal fluid in the lungs or heart complications.
• Seizures or loss of consciousness: Low calcium or high phosphate can cause neurological emergencies.
• No urine output for 12+ hours: A sign of kidney failure.
• Irregular or very fast heartbeat: High potassium can cause dangerous arrhythmias.
• Severe muscle weakness or paralysis: Especially if it affects breathing or movement.
• Confusion, hallucinations, or extreme lethargy: Could indicate electrolyte imbalances affecting the brain.

Do not wait—TLS can progress to cardiac arrest or kidney failure within hours. If you are undergoing cancer treatment, discuss an emergency plan with your healthcare team beforehand.

Source: American College of Emergency Physicians (ACEP)

Tumor lysis syndrome is a serious but manageable complication of cancer treatment. With early detection, preventive measures, and prompt treatment, most patients recover fully. Always work closely with your oncology team to monitor your risk and respond quickly to any warning signs.